MRI and GPS tools to guide prostate cancer treatment
Part of Cancer, Kidney & urinary clinical trials.
This study uses MRI (a detailed body scan) and a GPS-like mapping approach to help people with certain prostate cancers make treatment choices. It may help you and your care team decide whether active surveillance (watching closely without immediate treatment) is a good fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer in the “very low” to “favorable intermediate” risk group
- You were diagnosed within the last 3 months
- You are a man age 40 to 76
- You’re willing to consider active surveillance as a treatment option
- You’re expected to live at least 10 years
- You can complete study surveys and questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether special MRI “risk maps” can help doctors better identify suspicious areas in the prostate during diagnosis. If you’re having an MRI followed by an MRI-guided biopsy, this may help improve how the biopsy targets areas of concern.
This study uses special prostate MRI scans to see how prostate cancer changes over time while you stay on active surveillance. It also looks at prostate tissue to understand your cancer’s genetics, which may help guide future decisions.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This trial studies whether men with low-risk prostate cancer can safely avoid treatment by closely monitoring their cancer over many years. It tests a new approach to see if it is better than the current standard of care.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
This study uses a genetic risk score and a special MRI scan to find prostate cancers that are more likely to be dangerous. It aims to see if combining these tests can better identify which men need a biopsy.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.